Maternal exposure to prescription and non-prescription pharmaceuticals or drugs of abuse and risk of craniosynostosis

Authors:

Abstract
The pre- and pen-natal drug exposures reported by women participating in a case-control study of children in Colorado were examined for association withinfant craniosynostosis. Mothers of case and control children underwent a standardized telephone interview and obstetric and newborn medical record review. The interview included questions on the use of prescription and non-prescription drugs, nutritional supplements, recreational and drugs of abuse. The mother's obstetric record was abstracted for information about pharmacologic agents taken before and during the antepartum period. There were no statistically significant risk ratios associating craniosynostosis with prenatal exposure to hydantoin, vaiproic acid, or cocaine. Mothers of four case children and one control child reported specific exposure to retinoic acid. There were no statisicafly significant increases in the odds ratio (OR) for any suture type among children exposed to hypoxigenic agents, sympathomimetic or parasympatholytic agents, or metal-containing agents. The OR was 1.87 (lower bound of the two-sided 95% test-based confidence interval (CI) : 1.08) among children with sagittal/lambdoid suture synostosis who were exposed to nitro satable drugs chiorpheniramine, chlordiazepoxide, and nitrofurantoin compared to controls. Certain nitrosatable drugs may be associated with increased risk of infant sagittal/lambdoid craniosynostosis. A possible mechanism related to ischaernia/ reperfusion injury is suggested.

This publication has 10 references indexed in Scilit: